Potential survival benefit of polymyxin B hemoperfusion in patients with septic shock

ccforum.biomedcentral.com June 8, 2017

potential-survival-benefit-of-polymyxin-b-hemoperfusion-in-patients-with-septic-shock

The purpose of this study was to investigate whether polymyxin B hemoperfusion (PMX-HP) improves the survival of patients with septic shock. Our results strongly suggest that PMX-HP reduces all-cause hospital mortality and length of ICU stay in patients with septic shock.

ICU mortality sepsis septic shock study

Fluid Personalization and Vasopressor Decisions in Early Sepsis Management

Fluid Personalization and Vasopressor Decisions in Early Sepsis Management

Scientific Study Validates Usability of Post-ICU Digital Diary for Families of ICU Patients

Scientific Study Validates Usability of Post-ICU Digital Diary for Families of ICU Patients

AKI Risk Factors in ICU Patients Using Colistin

AKI Risk Factors in ICU Patients Using Colistin

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

Understanding the Essentials of Critical Care Nursing

Handbook of ICU EEG Monitoring

Atlas of Interventional Pain Management

Advances in Critical Care Pediatric Nephrology: Point of Care Ultrasound and Diagnostics

COPD: Heterogeneity and Personalized Treatment

Pediatric Liver Intensive Care

Better: A Surgeon’s Notes on Performance

Sepsis Management: PIRO and MODS

Extracorporeal Life Support for Adults

COVID-19 Airway Management and Ventilation Strategy for Critically Ill Older Patients

Critical Care: A New Nurse Faces Death, Life, and Everything in Between